Identification of potential inhibitors for severe acute respiratory syndrome-related coronavirus 2 (SARS-CoV-2) angiotensin-converting enzyme 2 and the main …

N Kılınç, M Açar, S Tuncay… - Letters in Drug Design & …, 2022 - ingentaconnect.com
Background: The 2019 novel coronavirus disease (COVID-19) has caused a global health
catastrophe by affecting the human population around the globe. Unfortunately, there is no …

Molecular docking and ADMET prediction of natural compounds towards SARS Spike glycoprotein-human angiotensin-converting enzyme 2 and SARS-CoV-2 main …

BJ Oso, IF Olaoye, SO Omeike - Archives of Razi Institute, 2021 - archrazi.areeo.ac.ir
More than a decade ago, a novel coronavirus that infects humans, bats, and certain other
mammals termed severe acute respiratory syndrome coronavirus (SARS-CoV) caused an …

[HTML][HTML] In-silico analysis of the inhibition of the SARS-CoV-2 main protease by some active compounds from selected African plants

HI Umar, SS Josiah, TP Saliu, TO Jimoh, A Ajayi… - Journal of Taibah …, 2021 - Elsevier
Abstract Objectives Over the years, Azadirachta indica, Mangifera indica, and Moringa
oleifera have been shown to possess some antiviral characteristics. This study applies …

[PDF][PDF] In silico screening of natural compounds against COVID-19 by targeting Mpro and ACE2 using molecular docking.

T Joshi, P Sharma, S Mathpal, H Pundir… - European Review for …, 2020 - researchgate.net
OBJECTIVE: Currently, Coronavirus COVID-19 is spreading worldwide very rapidly and its
control is very difficult because there is no effective vaccine or drugs available in markets …

Potential of Plant Bioactive Compounds as SARS‐CoV‐2 Main Protease (Mpro) and Spike (S) Glycoprotein Inhibitors: A Molecular Docking Study

TE Tallei, SG Tumilaar, NJ Niode, fnm Fatimawali… - …, 2020 - Wiley Online Library
Since the outbreak of the COVID‐19 (coronavirus disease 19) pandemic, researchers have
been trying to investigate several active compounds found in plants that have the potential to …

Virtual screening, drug-likeness analysis, and molecular docking study of potentialsevere acute respiratory syndrome coronavirus 2 main protease inhibitors

N NEDELJKOVIC, M Nikolic… - Turkish Journal of …, 2022 - journals.tubitak.gov.tr
Due to the length of time required to develop specific antiviral agents, the World Health
Organization adopted the strategy of repurposing existing medications to treat Coronavirus …

Virtual Screening of Artemisia annua Phytochemicals as Potential Inhibitors of SARS-CoV-2 Main Protease Enzyme

K Miandad, A Ullah, K Bashir, S Khan, SA Abideen… - Molecules, 2022 - mdpi.com
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a human coronaviruses
that emerged in China at Wuhan city, Hubei province during December 2019. Subsequently …

In silico evaluation of Iranian medicinal plant phytoconstituents as inhibitors against main protease and the receptor-binding domain of SARS-CoV-2

SS Mousavi, A Karami, TM Haghighi, SG Tumilaar… - Molecules, 2021 - mdpi.com
The novel coronavirus disease 2019 (COVID-19) is caused by the severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2), which initially appeared in Wuhan, China, in …

In silico identification of potentially effective herbal inhibitors of SARS-Cov-2 main protease by virtual screening method

AD Beirami, D Hatamabadi, S Iranpanah… - School of Medicine …, 2020 - journals.sbmu.ac.ir
Background: The COVID-19 pandemic is a global health emergency caused by SARS-CoV-
2. Unfortunately, no effective drugs have been found to date. There is also a major need for …

Combined molecular docking and dynamics simulations studies of natural compounds as potent inhibitors against SARS-CoV-2 main protease

M Ouassaf, S Belaidi, S Chtita, T Lanez… - Journal of …, 2022 - Taylor & Francis
Main protease (Mpro) of SARS-CoV-2 is a key CoV enzyme that plays a pivotal role in
mediating viral replication and transcription, making it an attractive drug target for SARS …